Today, The Panic-Proof Portfolio (Stockchase Research) and Gordon Reid commented about whether FCX-N, DY-N, CB-N, MMM-N, UAL-Q, GM-N, F-N, TSLA-Q, V-N, FDX-N, META-Q, ABBV-N, JPM-N, JEC-N, JNJ-N, GD-N, KO-N, PFE-N, HYLN-N, UNP-N, VFF-Q, HEXO-T, APHA-T, TLT-Q, SHOP-T, SLP-Q are stocks to buy or sell.
This morning the news said that distribution has been halted in the US, so the stock is declining today. Like Pfzier, JNJ is seeing a one-time bump because of their vaccine. JNJ is struggling in their consumer business as consumers move to generic drugs, not branded. Also, litigation remains a cloud, referring to asbestos in its Baby Powder. There are other opportunities in healthcare, like Anthem, the insurer, or retailer CVS, or Abbvie trading at a reasonable PE and offers good growth.
It's a safe, solid choice, likely the best-run bank in the world under a superb CEO. There's still money to be made in the banks. JPM reports tomorrow. He wants to hear about their loan growth and net interest margins during this steeper yield curve. They've excelled in capital markets as SPACs continue to hum and he expects this to continue. They have many years of cost-cutting. BAC has slightly more upside, though.